Evidence map›Paper›PMID 41745464›Full record

ReviewMarine drugs2026

Angélica R Soares, Nathalia Nocchi, Ana R Díaz-Marrero, Renato C Pereira, José J Fernández

Abstract readReview
In one paragraph

Review in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Laurinterol, the MainMarine drugs · 2026
    Review
  2. Marine drugs · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Angélica R SoaresGrupo de Produtos Naturais de Organismos Aquáticos (GPNOA), Instituto de Biodiversidade e Sustentabilidade (NUPEM), Universidade Federal do Rio de Janeiro (UFRJ), Av. São José do Barreto 764, São José do Barreto, Macaé 27965-045, Rio de Janeiro, Brazil.ORCID 0000-0001-9126-3778
Nathalia NocchiInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain.ORCID 0000-0001-6811-1581
Ana R Díaz-MarreroBiotecnología Marina, IUBO-ULL, Unidad Asociada al IPNA-CSIC, 38206 La Laguna, Tenerife, Spain.ORCID 0000-0002-8886-7519
Renato C PereiraDepartament of Marine Biology, Biology Institute, Federal Fluminense University-UFF, Niterói 21941-590, Rio de Janeiro, Brazil.ORCID 0000-0001-7576-226X
José J FernándezInstituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain.ORCID 0000-0002-0805-8317

Funding

Conselho Nacional de Pesquisas e Desenvolvimento Científico e Tecnológico e Inovação CNPqFundação de Amparo à Pesquisa do Estado do Rio de Janeiro FAPERJGobierno de Canarias ProID2024010033 (BIMICMAR)Gobierno de Canarias Promotur Islas Canarias (PROMOTUR_SP3)
6 · The paper itself

Abstract

The concept of "

Indexed as

Aquatic OrganismsBiological ProductsLaurenciaSesquiterpenesAnimalsDrug DiscoveryHumansSeaweedSecondary MetabolismSpiro CompoundsBiological ProductselatolSesquiterpenesSpiro Compounds(+)-elatol(−)-elatolmarine chamigrenemarine natural productmarine sesquiterpeneSmart Secondary Metabolite

Identifiers

PMID41745464
PMCPMC12942527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.